Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
401
-
Total 13F shares, excl. options
-
47.7M
-
Shares change
-
+4.55M
-
Total reported value, excl. options
-
$6.46B
-
Value change
-
+$611M
-
Put/Call ratio
-
0.95
-
Number of buys
-
192
-
Number of sells
-
-176
-
Price
-
$135.38
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2017
463 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q1 2017.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 401 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.7M shares
.
Largest 10 shareholders include BlackRock Inc. (4.74M shares), FMR LLC (4.14M shares), VANGUARD GROUP INC (3.79M shares), SCOPIA CAPITAL MANAGEMENT LP (2.37M shares), STATE STREET CORP (2M shares), Palo Alto Investors, LLC (1.88M shares), AQR CAPITAL MANAGEMENT LLC (1.74M shares), AJO, LP (1.69M shares), LSV ASSET MANAGEMENT (1.26M shares), and GOLDMAN SACHS GROUP INC (1.15M shares).
This table shows the top 401 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.